Accountability did, and it can save you too
Although its selectivity is not necessarily superior to existing inhibitors, DLK1 competes with MSTN for binding to ActRIIB and promotes muscle regeneration through modulation of SMAD2/3 and Notch signaling pathways.[88] However, to date, no clinical trials have investigated DLK1 activation or overexpression as a strategy to promote muscle growth, although such studies may offer promising therapeutic opportunities for the management of metabolic disorders
Exercise, particularly cardiovascular activities like running or swimming, burns additional calories and keeps your metabolism humming
In reality, treatment decisions are much more individualized
Nutritional Risks of Combining Fasting and GLP-1 Therapy The biggest risk when merging intermittent fasting with GLP-1 use is consuming too few calories during eating windows, leading to protein deficiency, micronutrient gaps, and loss of lean muscle mass
[2] Your oncology team will help you understand the right length of therapy for your situation based on the latest guidelines and your individual risk factors
